Simplex Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Simplex Trading’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,626	Closed	-$63K	–	9860
2025 Q3	$63K	Sell	8,626 -2,777	-24%	-$23.6K	﹤0.01%	6228
2025 Q2	$86K	Buy	+11,403	New	+$178K	﹤0.01%	5393
2024 Q3	–	Sell	-121	Closed	-$2.69K	–	9428
2024 Q2	$3K	Buy	+121	New	+$5.5K	﹤0.01%	8151
2024 Q1	–	Sell	-2,261	Closed	-$179K	–	9729
2023 Q4	$232K	Buy	2,261 +201	+10%	+$18K	﹤0.01%	4518
2023 Q3	$201K	Buy	2,060 +537	+35%	+$50.1K	﹤0.01%	4347
2023 Q2	$178K	Buy	+1,523	New	+$193K	﹤0.01%	4433
2023 Q1	–	Sell	-515	Closed	-$45K	–	9978
2022 Q4	$43K	Sell	515 -590	-53%	-$45K	﹤0.01%	6064
2022 Q3	$35K	Buy	1,105 +1,102	+36,733%	+$30.4K	﹤0.01%	6898
2022 Q2	$0	Sell	3 -64	-96%	-$2.24K	﹤0.01%	10925
2022 Q1	$3K	Buy	+67	New	+$2.67K	﹤0.01%	9732

Other funds holding RVPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Simplex Trading's RVPH Position: Q4 2025 in Review

Simplex Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2025, closing a stake of 8,626 shares — an estimated $63K sold.

Simplex Trading first reported a position in RVPH in Q1 2022 and held it in 10 quarters. The position peaked at $232K in Q4 2023. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

Simplex Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 8,626 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $63K.
Simplex Trading first reported a position in REVIVA PHARMA HLDGS INC in Q1 2022 and held it in 10 quarters.
Simplex Trading's REVIVA PHARMA HLDGS INC position peaked at $232K in Q4 2023.
48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.